Medicure Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
126.60
493.90
3,568.60
25,075.20
5,260.50
71,886.30
Total Accounts Receivable
432.60
1,637.70
9,823.60
17,200.80
91,266.60
10,764.60
Inventories
902.80
1,099.60
2,289.30
12,176.60
3,075.00
4,239.30
Other Current Assets
29.50
643.00
1,767.10
759.10
14,956.80
2,696.70
Total Current Assets
1,491.50
3,874.10
17,448.60
55,211.70
114,558.90
89,586.80
Net Property, Plant & Equipment
22.20
33.20
230.20
10,300.60
221.60
316
Total Investments and Advances
-
1,556.30
1,787.20
-
-
-
Long-Term Note Receivable
-
-
-
-
12,068.80
11,909.40
Intangible Assets
1,910.10
1,096.90
1,412.00
148,350.40
1,756.30
1,705.30
Other Assets
-
-
-
161.90
-
116.80
Total Assets
3,423.80
6,560.50
21,256.90
214,725.70
128,931.70
103,761.40
ST Debt & Current Portion LT Debt
1,271.80
654.90
1,773.80
4,356.90
-
Accounts Payable
2,263.00
3,700.30
6,777.90
16,804.90
7,388.40
Income Tax Payable
-
-
-
504.60
2,428.60
Other Current Liabilities
22.30
22.30
1,800.80
39,894.30
33,857.00
Total Current Liabilities
3,557.00
4,377.50
10,352.50
61,560.60
43,673.90
Long-Term Debt
3,510.10
4,225.90
2,617.60
70,178.40
-
Deferred Taxes
-
-
379.00
37,441.80
326.10
Other Liabilities
683.30
1,868.10
3,825.30
6,560.00
4,548.60
Total Liabilities
7,750.50
10,471.50
16,795.30
176,441.80
48,222.50
Common Equity (Total)
4,326.70
3,911.00
4,461.60
36,193.90
80,709.20
Total Shareholders' Equity
4,326.70
3,911.00
4,461.60
36,193.90
80,709.20
Total Equity
4,326.70
3,911.00
4,461.60
38,283.90
80,709.20
Liabilities & Shareholders' Equity
3,423.80
6,560.50
21,256.90
214,725.70
128,931.70
Accumulated Minority Interest
-
-
-
2,090.00
-

About Medicure

View Profile
Address
1250 Waverley Street
Winnipeg Manitoba R3T 6C6
Canada
Employees -
Website http://www.medicure.com
Updated 07/08/2019
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of human therapeutics. It focuses on the marketing and distribution ofits acute care cardiovascular drug, AGGRASTAT. The company was founded by Albert D.